Literature DB >> 19264912

Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine.

Paul Jedlicka1, Xiaomei Sui, Lori Sussel, Arthur Gutierrez-Hartmann.   

Abstract

Members of the Ets transcription factor family are widely expressed in both the developing and mature mammalian intestine, but their biological functions remain primarily uncharacterized. We used a dominant repressor transgene approach to probe the function of epithelial Ets factors in the homeostasis of the crypt-villus unit, the functional unit of the small intestine. We show that targeted expression in small intestinal epithelium of a fusion protein composed of the Engrailed repressor domain and the Erm DNA-binding domain (En/Erm) results in marked disruption of normal crypt-villus homeostasis, including a cell-autonomous disturbance of epithelial maturation, increased epithelial transit, severe villus dysmorphogenesis, and crypt dysmorphogenesis. The epithelial maturation disturbance is independent of the regulation of TGFbetaRII levels, in contrast to Ets-mediated epithelial differentiation during development; rather, regulation of Cdx2 expression may play a role. The villus dysmorphogenesis is independent of alterations in the crypt-villus boundary and inappropriate beta-catenin activation, and thus appears to represent a new mechanism controlling villus architectural organization. An Analysis of animals mosaic for En/Erm expression suggests that crypt nonautonomous mechanisms underlie the crypt dysmorphogenesis phenotype. Our studies thus uncover novel Ets-regulated pathways of intestinal homeostasis in vivo. Interestingly, the overall En/Erm phenotype of disturbed crypt-villus homeostasis is consistent with recently identified Ets function(s) in the restriction of intestinal epithelial tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264912      PMCID: PMC2671360          DOI: 10.2353/ajpath.2009.080409

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium.

Authors:  Kevin Haigis; Julien Sage; Jon Glickman; Sarah Shafer; Tyler Jacks
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

2.  Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic patterning.

Authors:  Martyn Donnison; Angela Beaton; Helen W Davey; Ric Broadhurst; Phil L'Huillier; Peter L Pfeffer
Journal:  Development       Date:  2005-04-13       Impact factor: 6.868

Review 3.  Twists and turns in the development and maintenance of the mammalian small intestine epithelium.

Authors:  Andrew L Hauck; Kelly S Swanson; Paul J A Kenis; Deborah E Leckband; H Rex Gaskins; Lawrence B Schook
Journal:  Birth Defects Res C Embryo Today       Date:  2005-03

4.  Targeting of the ETS factor GABPalpha disrupts neuromuscular junction synaptic function.

Authors:  Debra A O'Leary; Peter G Noakes; Nick A Lavidis; Ismail Kola; Paul J Hertzog; Sika Ristevski
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 5.  ETS transcription factors in endocrine systems.

Authors:  Arthur Gutierrez-Hartmann; Dawn L Duval; Andrew P Bradford
Journal:  Trends Endocrinol Metab       Date:  2007-03-26       Impact factor: 12.015

6.  Ets2 is necessary in trophoblast for normal embryonic anteroposterior axis development.

Authors:  Pantelis Georgiades; Janet Rossant
Journal:  Development       Date:  2006-02-15       Impact factor: 6.868

7.  Epithelial hedgehog signals pattern the intestinal crypt-villus axis.

Authors:  Blair B Madison; Katherine Braunstein; Erlene Kuizon; Kathleen Portman; Xiaotan T Qiao; Deborah L Gumucio
Journal:  Development       Date:  2004-12-08       Impact factor: 6.868

8.  Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.

Authors:  Nina M Muñoz; Melissa Upton; Andres Rojas; M Kay Washington; Li Lin; Anna Chytil; Elif G Sozmen; Blair B Madison; Ambra Pozzi; Randall T Moon; Harold L Moses; William M Grady
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

9.  ERM is required for transcriptional control of the spermatogonial stem cell niche.

Authors:  Chen Chen; Wenjun Ouyang; Vadim Grigura; Qing Zhou; Kay Carnes; Hyunjung Lim; Guang-Quan Zhao; Silvia Arber; Natasza Kurpios; Theresa L Murphy; Alec M Cheng; John A Hassell; Varadaraj Chandrashekar; Marie-Claude Hofmann; Rex A Hess; Kenneth M Murphy
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

Review 10.  Ets transcription factors in intestinal morphogenesis, homeostasis and disease.

Authors:  Paul Jedlicka; Arthur Gutierrez-Hartmann
Journal:  Histol Histopathol       Date:  2008-11       Impact factor: 2.303

View more
  9 in total

1.  Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2).

Authors:  Mette Boyd; Morten Hansen; Tine G K Jensen; Anna Perearnau; Anders K Olsen; Lotte L Bram; Mads Bak; Niels Tommerup; Jørgen Olsen; Jesper T Troelsen
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

2.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Jeong Mo Bae; Tae Hun Lee; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.

Authors:  E L McKinsey; J K Parrish; A E Irwin; B F Niemeyer; H B Kern; D K Birks; P Jedlicka
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

4.  The prostate cancer TMPRSS2:ERG fusion synergizes with the vitamin D receptor (VDR) to induce CYP24A1 expression-limiting VDR signaling.

Authors:  Jung-Sun Kim; Justin M Roberts; William E Bingman; Longjiang Shao; Jianghua Wang; Michael M Ittmann; Nancy L Weigel
Journal:  Endocrinology       Date:  2014-06-13       Impact factor: 4.736

5.  Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

Authors:  Hanna B Kern; Brian F Niemeyer; Janet K Parrish; Carol A Kerr; Nasser K Yaghi; Jason D Prescott; Arthur Gutierrez-Hartmann; Paul Jedlicka
Journal:  DNA Cell Biol       Date:  2012-05-03       Impact factor: 3.311

6.  Fibroblast growth factor 10 represses premature cell differentiation during establishment of the intestinal progenitor niche.

Authors:  Pia Nyeng; Maureen Ann Bjerke; Gitte Anker Norgaard; Xiaoling Qu; Sune Kobberup; Jan Jensen
Journal:  Dev Biol       Date:  2010-09-27       Impact factor: 3.582

7.  A single-cell atlas of chromatin accessibility in the human genome.

Authors:  Kai Zhang; James D Hocker; Michael Miller; Xiaomeng Hou; Joshua Chiou; Olivier B Poirion; Yunjiang Qiu; Yang E Li; Kyle J Gaulton; Allen Wang; Sebastian Preissl; Bing Ren
Journal:  Cell       Date:  2021-11-12       Impact factor: 41.582

Review 8.  Intestinal mucosal atrophy and adaptation.

Authors:  Darcy Shaw; Kartik Gohil; Marc D Basson
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

9.  The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice.

Authors:  Paul Jedlicka; Xiaomei Sui; Arthur Gutierrez-Hartmann
Journal:  BMC Cancer       Date:  2009-06-22       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.